In the news
24 July 2015 – Julie-Anna Needham, Dealreporter, speaks on Share Radio’s Morning Money Show
The Power of Dealreporter
Mindray Medical International receives take private proposal at USD 30 per share
On 5 March, Dealreporter revealed that Mindray Medical International was a logical take-private target. Industry sources suggested that the company was undervalued by investors despite being one of China’s largest medical device companies.
On 4 June, Mindray revealed it had received a non-binding proposal letter from Li Xiting, its executive chairman, and Cheng Minghe, its co-chief executive, for a take-private offer at USD 30 per American Depositary Share.
21 July, 2015 - 9:25 am UTC
Europe Flash: BB Biotech’s NAV discount ripe for activists, Sinclair IS Pharma strategic review, Dustin Group lock-up
Shareholder activist could look to unlock value at BB Biotech
21 July, 2015 - 4:39 am UTC
Taikang Life and China Huarong Asset Management in pipeline
20 July, 2015 - 12:50 pm UTC
Chinese companies undeterred by A-share hiccups